Latest News
Rhythm Pharmaceuticals, Inc.
- Rhythm Pharmaceuticals, Inc. Estimates – FWB:1RV
- Two healthcare conferences will feature Rhythm’s CEO and CFO after its Nov. 3 results call.
- Did Japan Launch Just Shift Rhythm Pharmaceuticals (RYTM) Investment Narrative?
- Rhythm Pharmaceuticals (RYTM) Dropped, So What Is Driving Attention Now?
- William Blair initiates Rhythm Pharmaceuticals stock with outperform rating By Investing.com
- JPMorgan cuts target for Rhythm Pharmaceuticals stock to USD 145.00
- Rhythm Pharmaceuticals (NasdaqGM:RYTM) Stock Forecast & Analyst Predictions
- Rhythm Pharmaceuticals launches IMCIVREE in Japan for obesity
- Rhythm Pharmaceuticals Announces Commercial Launch of
- Here’s How Much You Would Have Made Owning Rhythm Pharmaceuticals Stock In The Last 5 Years
- Investigation launched into Rhythm Pharmaceuticals' executives for possible self-dealing harming shareholders
- Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law Firm
Headlines from the last 30 days, linking to the original publishers. See all market news →